CRISPR Therapeutics AG Quarterly Common Stock, Shares, Issued from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
CRISPR Therapeutics AG quarterly Common Stock, Shares, Issued history and growth rate from Q4 2015 to Q3 2024.
  • CRISPR Therapeutics AG Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 85.5M shares, a 7.41% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 85.5M +5.9M +7.41% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 85.2M +5.66M +7.12% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 85M +5.96M +7.55% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 80.2M +1.52M +1.93% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 79.6M +1.18M +1.5% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 79.6M +1.58M +2.03% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 79M +1.48M +1.91% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 78.7M +1.52M +1.97% Dec 31, 2022 10-K 2024-02-21
Q3 2022 78.4M +1.78M +2.33% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 78M +1.7M +2.23% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 77.6M +1.64M +2.16% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 77.2M +3.06M +4.13% Dec 31, 2021 10-K 2023-02-21
Q3 2021 76.6M +5.84M +8.26% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 76.3M +13.5M +21.6% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 75.9M +14.8M +24.2% Mar 31, 2021 10-Q 2021-04-27
Q4 2020 74.1M +13.1M +21.4% Dec 31, 2020 10-K 2022-02-15
Q3 2020 70.8M +15.4M +27.7% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 62.7M +8.99M +16.7% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 61.1M +8.18M +15.4% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 61M +8.87M +17% Dec 31, 2019 10-K 2021-02-16
Q3 2019 55.4M +3.58M +6.91% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 53.8M +6.27M +13.2% Jun 30, 2019 10-Q 2019-07-29
Q1 2019 52.9M +5.82M +12.4% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 52.2M +11.1M +27.1% Dec 31, 2018 10-K 2020-02-12
Q3 2018 51.9M +11M +27% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 47.5M +7M +17.3% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 47.1M Mar 31, 2018 10-Q 2018-05-08
Q4 2017 41M +873K +2.17% Dec 31, 2017 10-K 2019-02-25
Q3 2017 40.8M +35.2M +621% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 40.5M Jun 30, 2017 10-Q 2017-08-10
Q4 2016 40.2M +34.6M +627% Dec 31, 2016 10-K 2018-03-08
Q3 2016 5.66M Sep 30, 2016 10-Q 2016-11-22
Q4 2015 5.53M Dec 31, 2015 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.